Sativex

Sativex is licensed for the treatment of spasticity in adults with multiple sclerosis (MS). This is specifically for patients whose spasticity has not been adequately improved by other treatments.

Sativex is available in the UK, but as a prescription-only medicine.

Sativex is a licensed medical cannabis product which can be prescribed via the NHS for some patients with treatment resistant spasticity from multiple sclerosis (MS). There are very few medical cannabis prescriptions on the NHS. Patients with other reasons why medical cannabis may be appropriate, will need to seek treatment via a private clinic, such as Curaleaf Clinic.

Sativex contains tetrahydrocannabinol (THC) and like any preparation of cannabis which contains THC, it has the potential to cause euphoria or a ‘high’. This can be minimised by starting at a low dose which slowly increases overtime to achieve the desired clinical effect, whilst minimising the risk of side effects, such as this ‘high’.

Sativex, like all medications, may cause side effects. Some common side effects include:

• Dizziness
• Fatigue
• Nausea
• Dry mouth
• Appetite changes
• Constipation